These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 6627819

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
    Frishman WH, Michelson EL, Johnson BF, Poland MP.
    Am J Med; 1983 Oct 17; 75(4A):54-67. PubMed ID: 6356900
    [Abstract] [Full Text] [Related]

  • 4. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
    McNeil JJ, Louis WJ.
    Br J Clin Pharmacol; 1979 Oct 17; 8(Suppl 2):163S-166S. PubMed ID: 43164
    [Abstract] [Full Text] [Related]

  • 5. Hypertension in general practice: a comparative study of labetalol and metoprolol (+/- prazosin) in general practice.
    Piterman L.
    Aust Fam Physician; 1981 Jul 17; 10(7):579-83. PubMed ID: 7283872
    [No Abstract] [Full Text] [Related]

  • 6. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
    Pugsley DJ, Nassim M, Armstrong BK, Beilin L.
    Br J Clin Pharmacol; 1979 Jan 17; 7(1):63-8. PubMed ID: 367410
    [Abstract] [Full Text] [Related]

  • 7. Use of labetalol in moderate to severe hypertension.
    Macdonald I, Hua AS, Thomas GW, Woo KT, Whitworth JA, Kincaid-Smith P.
    Med J Aust; 1980 Apr 05; 1(7):325-7. PubMed ID: 7393061
    [Abstract] [Full Text] [Related]

  • 8. The effects of labetalol and prazosin on exercise haemodynamics in hypertensive patients.
    Feit A, Cohen M, Dimino L, el-Sherif N, Holtzman R, Venkata C, Ram S, Gaffeny D, Heller J, Kaplan N.
    J Hum Hypertens; 1991 Feb 05; 5(1):39-43. PubMed ID: 2041034
    [Abstract] [Full Text] [Related]

  • 9. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN.
    Drugs; 1984 Feb 05; 28 Suppl 2():51-68. PubMed ID: 6151891
    [Abstract] [Full Text] [Related]

  • 10. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    West MJ, Wing LM, Mulligan J, Walkley J, Grygiel JJ, Graham JR, Chalmers JP.
    Med J Aust; 1980 Mar 08; 1(5):224-5. PubMed ID: 6990215
    [Abstract] [Full Text] [Related]

  • 11. Effects of prazosin and labetalol on blood pressure control and blood lipid levels in patients with mild-to-moderate essential hypertension.
    Farry JP, Fischl SJ, Tighe MJ, Krell MJ.
    Am J Med; 1989 Jan 23; 86(1B):41-4. PubMed ID: 2643864
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical, ergometric and polygraphic evaluation of the effects of metoprolol and labetalol administration in essential arterial hypertension. Comparative study].
    Schirripa V, Attisano N, Sarica G, Grenci G, Martelli G.
    Minerva Med; 1982 Apr 02; 73(14):845-9. PubMed ID: 7070696
    [Abstract] [Full Text] [Related]

  • 14. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects.
    MacCarthy EP, Bloomfield SS.
    Pharmacotherapy; 1983 Apr 02; 3(4):193-219. PubMed ID: 6310529
    [Abstract] [Full Text] [Related]

  • 15. Treatment of hypertension in the elderly with labetalol.
    Eisalo A, Virta P.
    Acta Med Scand Suppl; 1982 Apr 02; 665():129-33. PubMed ID: 6961759
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the effects of combined or separate alpha- and beta-blockade in the treatment of hypertension in the acute stage of myocardial infarction.
    Renard M, Jacobs P, Liebens I, Abou Hamdam B, Bernard R.
    Int J Cardiol; 1986 Feb 02; 10(2):149-58. PubMed ID: 3080379
    [Abstract] [Full Text] [Related]

  • 17. Comparison of labetalol and prazosin in hypertensive patients using automated ambulatory monitoring.
    Gray JM, Silberman HM, Gorwit JI.
    Am J Med; 1988 May 02; 84(5):904-10. PubMed ID: 3284341
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension.
    Michelson EL, Frishman WH, Lewis JE, Edwards WT, Flanigan WJ, Bloomfield SS, Johnson BF, Lucas C, Freis ED, Finnerty FA.
    Am J Med; 1983 Oct 17; 75(4A):68-80. PubMed ID: 6356901
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.